The effect of Lactofem on the success of the IUI cycle

The effect of Lactofem in the success of the IUI cycle in infertile women

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230123057195N1

Enrollment

100

Registered

2024-01-27

Start date

2023-01-30

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female infertility

Interventions

Intervention 1: Intervention group: Infertile women using Lactofem, this drug is a synbiotic combination (probiotic + prebiotic) suitable for women and contains high amounts of 7 beneficial and safe b

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Infertile women candidates for IUI who have BMI less than 30

Exclusion criteria

Exclusion criteria: Infertile women with vaginitis or PID

Design outcomes

Primary

Measure	Time frame
Percentage of people who got pregnant. Timepoint: Measuring the prevalence of pregnancy after using Lactofem. Method of measurement: Laboratory blood test Beta HCG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Nazemi

Kashan University of Medical Sciences

z.nazemi91@gmail.com+98 31 5554 0676

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026